Hospital AI Lab L’IA médicale vue depuis la direction et les soins : informations pratiques pour les hôpitaux français

Mis à jour:

Technologie médicale et recherche en France

Que publie et que teste la France en médecine en ce moment ? Cette page réunit les articles dont les affiliations d’auteurs mentionnent la France et les essais de médicaments dont des sites sont en France, tous sur les 12 derniers mois, en trois groupes : techniques chirurgicales, nouveaux médicaments et traitements, études sur les maladies.

Période : du 2025-11-16 au 2026-11-16 · mise à jour automatique chaque semaine

Comment lire cette page
  • Il s’agit d’une liste automatique de titres, de revues, de dates et de liens issus de PubMed et de ClinicalTrials.gov. Nous ne copions ni les résumés ni le texte des articles, et nous n’avons pas vérifié les résultats.
  • L’existence d’un article ou d’un essai ne prouve pas qu’un traitement est efficace ou sûr, et ce n’est pas un avis médical. Interrogez votre médecin sur tout traitement.
  • « Articles de France » signifie qu’au moins une affiliation d’auteur mentionne le pays ; cela ne veut pas dire que toute l’étude a été menée en France.
  • Les titres sont affichés dans leur langue d’origine (le plus souvent l’anglais).

Techniques chirurgicales

Articles sur la chirurgie mini-invasive, assistée par robot, endoscopique, les prothèses articulaires et les greffes.

Affichage des 12 derniers sur 2 501 résultats

  1. Predictors and prognostic impact of spontaneous portal vein thrombosis recanalization in cirrhosis: An individual patient data meta-analysis

    Hepatol Commun 2026-11-11 Guerrero A, Del Campo L, Luca A et al. PMID 43013735

  2. Identification of a Novel KRAS::ETNK1 Fusion Transcript in a Myelodysplastic/Myeloproliferative Overlap Syndrome With Eosinophilia: A Case Report

    EJHaem 2026-11-01 Caledec M, Labussière-Wallet H, Fontaine J et al. PMID 42968844

  3. Regional and national variation in donor and recipient characteristics, transplant practice, and outcomes after liver transplantation (the IMPROVEMENT collaborative): a multicentre cohort study

    Lancet Reg Health Eur 2026-10-29 Avolio AW, Pascale MM, Lai Q et al. PMID 42999582

  4. Patient preference for intraoperative opioid strategy and early postoperative recovery after noncardiac surgery: a prospective partially randomised patient-preference trial (the PERFECT trial)

    BJA Open 2026-10-26 Gricourt Y, Boulos NM, Delaporte A et al. PMID 42990960

  5. Neurosurgical scalp incisions should preserve at least one vascular axis: Two case reports

    JPRAS Open 2026-10-23 Lupon E, Hertzog B, Njessi P et al. PMID 42997735

  6. A multivariate plasma biomarker model for glioblastoma exclusion: a retrospective case-control study

    Transl Oncol 2026-10-23 Decarpentrie J, David C, Donis N et al. PMID 42925769

  7. Aortic dilatation and gastrointestinal disease: expansion of the hyperinsulinism-polycystic kidney disease phenotype

    J Endocr Soc 2026-10-21 Yau D, Diaz-Moreno U, Cervi E et al. PMID 43016986

  8. Maternal and neonatal outcomes in pregnancies with cystic fibrosis after lung transplantation or during elexacaftor/tezacaftor/ivacaftor (ETI) therapy: a single-center descriptive cohort

    Eur J Obstet Gynecol Reprod Biol 2026-10-19 Le Bars S, Tissot A, Danner-Boucher I et al. PMID 42914615

  9. Preliminary experience with controlled hypothermic storage of donor heart in combined heart transplantation

    JHLT Open 2026-10-14 Argaw ST, Lora Ronco L, Frering A et al. PMID 42999535

  10. Outcomes of hepatic artery thrombosis after paediatric liver transplantation (HEPATIC): an international, multicentre, retrospective registry study

    Lancet Child Adolesc Health 2026-10-14 Li W, Hartog H, Minetto J et al. PMID 42874625

  11. The Kerboull cross-plate: from the birth of a concept to the current indications

    Int Orthop 2026-10-14 Wegrzyn J, Kerboull L, Béjui-Hugues J et al. PMID 42869993

  12. One-year outcomes of hepatic artery stenosis after pediatric liver transplantation: Results from the international, multicenter HEPATIC registry

    Dig Liver Dis 2026-10-13 HEPATIC Study Group PMID 42869696

Nouveaux médicaments et traitements (articles)

Essais de phase 1 à 3 et essais randomisés de médicaments, d’anticorps, de vaccins et de nouveaux traitements.

Affichage des 12 derniers sur 782 résultats

  1. Association of sex and age on outcomes of maintenance treatment in pati​ents with advanced esophagogastric adenocarcinoma: an exploratory analysis of the randomized AIO-YMO-0111-MATEO trial

    J Cancer Res Clin Oncol 2026-11-13 Stocker G, Stelmach R, Lorenzen S et al. PMID 43024019

  2. Coated or chewable aspirin and a hybrid air pollution mitigation strategy in patients with atherosclerotic disease: rationale and design of the COATED-AIR randomized trial

    Eur Heart J Cardiovasc Pharmacother 2026-11-04 Bikdeli B, Talasaz AH, Bakhshandeh H et al. PMID 42772753

  3. Hand-Arm Bimanual Intensive Therapy Including Lower Extremities in Preschoolers With Bilateral Cerebral Palsy: A Randomized Clinical Trial

    JAMA Netw Open 2026-11-02 Araneda R, Ebner-Karestinos D, Paradis J et al. PMID 43018972

  4. Neoadjuvant botensilimab with or without balstilimab in pMMR and dMMR colon cancer: the phase 2 UNICORN trial

    Nat Med 2026-11-01 Ghelardi F, Ambrosini M, Raimondi A et al. PMID 42972108

  5. A Randomized, Double-Blind, Placebo-Controlled Study of the PD-1 Inhibitor Cetrelimab in Chronic Hepatitis B

    J Viral Hepat 2026-11-01 Asselah T, Kakuda TN, Kulke S et al. PMID 42934895

  6. Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study

    Lancet Oncol 2026-11-01 Borchmann P, van Meerten T, Iacoboni G et al. PMID 42933440

  7. Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: The OPERA I and II Randomized Clinical Trials

    JAMA Neurol 2026-11-01 Hauser SL, Bar-Or A, Giovannoni G et al. PMID 42832215

  8. Long-term efficacy of lebrikizumab in treating head, neck and face involvement in patients with moderate-to-severe atopic dermatitis

    J Dermatolog Treat 2026-10-19 Chovatiya R, de Bruin-Weller M, Alexis A et al. PMID 42895209

  9. Firmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and αC-helix compressing mutations

    Cancer Cell 2026-10-16 Le X, Wang J, Yu Y et al. PMID 42887497

  10. Postoperative chemotherapy reintroduction in good responders after colorectal liver metastases resection: A French randomized phase III trial - IRIMAD

    Dig Liver Dis 2026-10-09 Labiad C, Brouquet A, Bachet JB et al. PMID 42850173

  11. Astrocytic and Axonal Injury Biomarkers in AQP4 Antibody-Positive NMOSD: Insights From PREVENT and CHAMPION-NMOSD

    Neurol Neuroimmunol Neuroinflamm 2026-10-08 Wingerchuk DM, Bennett JL, Berthele A et al. PMID 42848984

  12. A phase III randomized study: Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine in healthy adults, adolescents, and children in India and healthy adolescents and children in South Africa

    Vaccine 2026-10-05 Bavdekar A, Chansinghakul D, Dhati RM et al. PMID 42832931

Essais de médicaments débutés cette année

Études de médicaments enregistrées sur ClinicalTrials.gov avec un site dans ce pays, les plus récentes d’abord.

Affichage des 12 derniers sur 601 résultats

  1. Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care

    NCT07542990 Phase: Phase 3 Début: 2026-11-15 Promoteur: University Hospital, Tours Affections: Delirium in the Intensive Care Unit Médicament / intervention: Dexmedetomidine, Midazolam

  2. Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

    NCT07781657 Phase: Phase 2 Début: 2026-11-15 Promoteur: Hoffmann-La Roche Affections: Alzheimer's Disease Médicament / intervention: RO7568282, Placebo

  3. Study of PM54 in Combination With Cytotoxic and Targeted Agents in Adult Participants With Advanced Malignancies

    NCT07839819 Phase: Phase 1 / Phase 2 Début: 2026-11-12 Promoteur: PharmaMar Affections: Advanced Solid Tumor Médicament / intervention: PM54, Irinotecan

  4. A Study to Test Different Doses of BI 3968621 When Given Alone or With Ezabenlimab in Patients With Advanced Cancer

    NCT07851103 Phase: Phase 1 Début: 2026-11-10 Promoteur: Boehringer Ingelheim Affections: Advanced Solid Tumour Médicament / intervention: BI 3968621, ezabenlimab

  5. A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa

    NCT07804082 Phase: Phase 3 Début: 2026-11-03 Promoteur: Assistance Publique - Hôpitaux de Paris Affections: Ventilator Associated Bacterial Pneumonia, Pseudomonas Aeruginosa Infection Médicament / intervention: Bacteriophages GMP, saline solution (placebo)

  6. DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers

    NCT07707895 Phase: Phase 1 / Phase 2 Début: 2026-11-03 Promoteur: Boehringer Ingelheim Affections: Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology Médicament / intervention: Obrixtamig, ZL-1310

  7. A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT)

    NCT07743671 Phase: Phase 3 Début: 2026-11-02 Promoteur: Vaderis Therapeutics AG Affections: Hereditary Hemorrhagic Telangiectasia Médicament / intervention: Engasertib, Placebo

  8. Study on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With Alcohol Use Disorder

    NCT07844720 Phase: Phase 2 Début: 2026-11-02 Promoteur: Institut National de la Santé Et de la Recherche Médicale, France Affections: Alcohol Use Disorder Médicament / intervention: Thiamine

  9. To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

    NCT07629583 Phase: Phase 1 Début: 2026-11-02 Promoteur: Genentech, Inc. Affections: Lupus Erythematosus, Systemic Médicament / intervention: Cevostamab, Tocilizumab

  10. Effects of Butyrate Enemas on Postoperative Intestinal Motility Disorders in Hirschsprung's Disease

    NCT03660176 Phase: Phase 3 Début: 2026-11-01 Promoteur: Assistance Publique Hopitaux De Marseille Affections: Hirschsprung's Disease Médicament / intervention: Sodium Butyrate, routine management

  11. Interest of Cryotherapy in Reducing Pain During Radial Arterial Blood Sampling

    NCT07408011 Phase: Phase 3 Début: 2026-11-01 Promoteur: University Hospital, Brest Affections: Chronic Respiratory Diseases Médicament / intervention: Apllication of medical device ice pack, Apllication of cream

  12. Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants

    NCT07443436 Phase: Phase 2 Début: 2026-11-01 Promoteur: Assistance Publique - Hôpitaux de Paris Affections: Interstitial Lung Disease Médicament / intervention: Azithromycin 250 mg x3/week (3 tablets/week), Prednisone 10 mg/day

Maladies et études en population

Cohortes nationales, registres et études en population sur l’incidence et la prévalence.

Affichage des 12 derniers sur 5 664 résultats

  1. Implementation of the Toronto guidelines for childhood cancer staging: experience from 65 population-based cancer registries participating in the BENCHISTA project

    ESMO Real World Data Digit Oncol 2026-11-09 Lopez-Cortes A, Burns D, Botta L et al. PMID 43036817

  2. Oral and anal detection of Treponema pallidum DNA among transgender women and travestis with high-titre syphilis in Brazil: findings from the MyTTrA study

    Lancet Reg Health Am 2026-11-05 Salle R, McCartney DJ, Grange PA et al. PMID 43034791

  3. Corrigendum to 'Maternal RSVpreF Immunisation Against Infant RSV Hospitalisation: nationwide population-based effectiveness and durability study' [The Lancet Regional Health - Europe Volume 67 (2026) 101756]

    Lancet Reg Health Eur 2026-11-05 Jabagi MJ, Bertrand M, Gabet A et al. PMID 43017178

  4. Patient-Reported Experiences of Long-Term Recovery and Persistent Psychosocial Burden in NMDAR Encephalitis

    Neurol Neuroimmunol Neuroinflamm 2026-11-02 Boeken OJ, Patricio V, Duda-Sikula M et al. PMID 42970741

  5. Factors associated with self-reported health status among older adults in the Greater Kampala Metropolitan Area, Uganda: a cross-sectional survey

    Glob Health Action 2026-11-02 Otim J, Golaz V, Ojiambo Wandera S et al. PMID 42969147

  6. Health-care burden of metabolic dysfunction-associated steatotic liver disease in European tertiary-care outpatient clinics (CONSTANS): a prospective multicentre cohort study

    Lancet Reg Health Eur 2026-10-29 Ratziu V, Dufour JF, Ponnaiah M et al. PMID 42999578

  7. The rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenarians

    J Hum Immun 2026-10-27 Mørk N, Jensen JA, Bastard P et al. PMID 42944855

  8. From black plates to backyard animals: Chigger communities associated with wild and domestic hosts and the environment in a rural village setting

    Int J Parasitol Parasites Wildl 2026-10-23 Chaisiri K, Koosakulnirand S, Thinphovong C et al. PMID 42966939

  9. Temporal trends in radiation-induced optic neuropathy: a meta-analysis

    Clin Transl Radiat Oncol 2026-10-18 Thariat J, Pham TN, Sochacki T et al. PMID 42997473

  10. Timing of outbreak-triggered unit-wide screening and COVID-19 outbreak size in long-term care and related social welfare facilities in Okinawa, Japan

    IJID Reg 2026-10-13 Xu YS, Takahashi K, Shimakawa Y et al. PMID 43001209

  11. Early outcomes of the Octapro balloon-expandable transcatheter heart valve in an unrestricted cohort of patients with aortic valve stenosis: the MyPro registry

    Int J Cardiol 2026-10-06 Ielasi A, Moscarella E, Verček G et al. PMID 42838146

  12. Association of the ANCA Kidney Risk Score With Kidney Failure in Anti-Glomerular Basement Membrane Disease

    Kidney Int Rep 2026-10-06 Caillard P, Vigneau C, Halimi JM et al. PMID 43017096

Source: PubMed · ClinicalTrials.gov